durvalumab
Pronunciation: dur-VAL-ue-mab
Other Name(s): Imfinzi®
Appearance: solution
mixed into larger bags of fluids
Drug Formulary information is intended for use by healthcare professionals. It is not intended to be medical advice. Some of the information, including information about funding for cancer drugs, does not apply to all patients. Cancer treatment plans are unique to each patient. If you are a patient, please speak with your healthcare team to understand how this information applies to you.
Drug Monograph
Apr 2024
Eligibility Forms
Durvalumab - Locally Advanced Unresectable Stage III Non-Small Cell Lung Cancer Following Concurrent Chemoradiation Durvalumab - In Combination with Etoposide and Platinum for Extensive-Stage Small Cell Lung Cancer Durvalumab - Locally Advanced Unresectable or Metastatic Biliary Tract Cancer Durvalumab in combination with Tremelimumab - Previously Untreated Unresectable or Metastatic Hepatocellular Carcinoma (HCC)Patient Info Sheet
Mar 2024
What it is used for
- For the treatment of certain types of lung or bladder cancers
- Durvalumab is an immunotherapy medication. For more information on immunotherapy medications, click here.